Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy
Open Access
- 1 December 2010
- journal article
- Published by Informa UK Limited in Journal of Pain Research
- Vol. 4, 1-10
- https://doi.org/10.2147/JPR.S12866
Abstract
Duloxetine is a serotonin-norepinephrine reuptake inhibitor approved by the US Food and Drug Administration for the treatment of fibromyalgia and painful diabetic neuropathy at doses of 60 mg daily. Duloxetine has been shown to significantly improve the symptoms of chronic pain associated with these disorders, as measured by the Fibromyalgia Impact Questionnaire, Brief Pain Inventory scores, the Clinical Global Impressions Scale, and other various outcome measures in several placebo-controlled, randomized, double-blind, multicenter studies. Symptom improvement generally began within the first few weeks, and continued for the duration of the study. In addition, the efficacy of duloxetine was found to be due to direct effects on pain symptoms rather than secondary to improvements in depression or anxiety. Adverse events including nausea, constipation, dry mouth, and insomnia, were mild and transient and occurred at relatively low rates. In conclusion, duloxetine, a selective inhibitor for the serotonin and norepinephrine transporters, is efficacious in the treatment of chronic pain associated with fibromyalgia or diabetic neuropathy, and has a predictable tolerability profile, with adverse events generally being mild to moderate.Keywords
This publication has 38 references indexed in Scilit:
- Painful Diabetic Neuropathy: Epidemiology, Natural History, Early Diagnosis, and Treatment OptionsPain Medicine, 2008
- Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial ☆Pain, 2008
- Fibromyalgia.2007
- Serotonin Syndrome Precipitated by Linezolid in a Medically Ill Patient on DuloxetineJournal of Clinical Psychopharmacology, 2006
- A randomized controlled trial of duloxetine in diabetic peripheral neuropathic painNeurology, 2006
- A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorderPain, 2005
- A Double-Blind, Randomized Multicenter Trial Comparing Duloxetine with Placebo in the Management of Diabetic Peripheral Neuropathic PainPain Medicine, 2005
- Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteersClinical Pharmacology & Therapeutics, 2003
- Classification, epidemiology, and natural history of fibromyalgiaCurrent Pain and Headache Reports, 2001
- Assessment of the Serotonin and Norepinephrine Reuptake Blocking Properties of Duloxetine in Healthy SubjectsNeuropsychopharmacology, 2001